-+ 0.00%
-+ 0.00%
-+ 0.00%

KAZIA THERAPEUTICS ANNOUNCES THE LAUNCH OF A GROUNDBREAKING TRIAL WITH PAXALISIB IN COMBINATION WITH IMMUNOTHERAPY IN WOMEN WITH ADVANCED BREAST CANCER

Reuters·01/30/2025 12:30:20

Please log in to view news